Preclinical News and Research

RSS
TGen, Scottsdale Healthcare open INNO-206 Phase 2 trial for pancreatic cancer

TGen, Scottsdale Healthcare open INNO-206 Phase 2 trial for pancreatic cancer

Study reveals molecular link between aging and cancer

Study reveals molecular link between aging and cancer

Advaxis announces publication of preclinical research with ADXS-PSA

Advaxis announces publication of preclinical research with ADXS-PSA

NCATS' Therapeutics Discovery program gains more industry collaborators

NCATS' Therapeutics Discovery program gains more industry collaborators

Acorda commences AMPYRA clinical study for post-stoke deficits

Acorda commences AMPYRA clinical study for post-stoke deficits

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

DNDi, Astellas partner on new drug discovery research for treatment of NTDs

DNDi, Astellas partner on new drug discovery research for treatment of NTDs

CRT, BioInvent partner to identify new therapeutic antibodies in oncology

CRT, BioInvent partner to identify new therapeutic antibodies in oncology

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

HackensackUMC recognizes AcquiSci d-OSAB technology with research award

HackensackUMC recognizes AcquiSci d-OSAB technology with research award

Cebix announces data from Ersatta Phase 1 study on type 1 diabetes

Cebix announces data from Ersatta Phase 1 study on type 1 diabetes

Effective ways of detecting onset of kidney disease

Effective ways of detecting onset of kidney disease

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

CDI introduces MyCell Services

CDI introduces MyCell Services

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing

CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing

Arrowhead initiates final IND-enabling steps for ARC-520 to treat HBV

Arrowhead initiates final IND-enabling steps for ARC-520 to treat HBV

PhaseBio raises $48.4M in Series B financing

PhaseBio raises $48.4M in Series B financing

SANUWAVE’s ESWT stimulates proliferation of cambium cells for bone generation

SANUWAVE’s ESWT stimulates proliferation of cambium cells for bone generation

Esperance presents results from EP-100 Phase 1 study on solid tumors at ASCO annual meeting

Esperance presents results from EP-100 Phase 1 study on solid tumors at ASCO annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.